Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Phase 3
×
tremelimumab
×
Gastrointestinal
×
Clear all
Filters
3
NCT05883644
2026-02-18
SIERRA
AstraZeneca
Phase 3
Active not recruiting
111 enrolled
NCT03298451
2026-01-14
HIMALAYA
AstraZeneca
Phase 3
Active not recruiting
1,324 enrolled
31 charts
1 FDA
NCT06921785
2026-01-09
ARTEMIDE-HCC01
AstraZeneca
Phase 3
Recruiting
1,220 enrolled
NCT05557838
2025-02-07
TREMENDOUS
AstraZeneca
Phase 3
Recruiting
210 enrolled
NCT05301842
2025-01-15
EMERALD-3
AstraZeneca
Phase 3
Active not recruiting
760 enrolled